miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
about
miR-509-3p alteration of YAP1/ECM axisTumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour.Associations of five polymorphisms in the CD44 gene with cancer susceptibility in Asians.Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling.SPARC overexpression alters microRNA expression profiles involved in tumor progressionCG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.MicroRNA‑1288 promotes cell proliferation of human glioblastoma cells by repressing ubiquitin carboxyl‑terminal hydrolase CYLD expression.Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.
P2860
Q30230882-5184836F-995A-4325-9F72-D0C7793082EFQ37464162-5A063329-BF5C-4C72-BE46-6ED19860380FQ37522311-4164991C-3D3E-4883-A3FA-3066753B1127Q37728657-97859762-39E2-4FC4-894E-98634A51D15EQ38729651-CA12B880-6371-4D70-AB54-13D738018C1EQ38823959-DCF5F596-AC2D-4AA8-8AA9-4BD82B756A18Q41546447-AEE0C36A-6307-4643-8314-87B92945D769Q47367402-EBF7E2D4-DD51-4AD8-BE67-AC0932CBCD0FQ49593669-3DA22426-EE17-4504-A4E9-CDA964230836Q49852347-497A9136-91E2-452A-9B10-AA16388BC946Q50122609-E526C16D-09F9-40EA-BB5E-334D3E468BC7Q54940097-59325B5F-B1F0-480B-A2E4-9548C1D62B15
P2860
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@en
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@nl
type
label
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@en
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@nl
prefLabel
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@en
miR-509-3p is clinically signi ...... r spheroids in ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
miR-509-3p is clinically signi ...... ar spheroids in ovarian cancer
@en
P2093
Amy C Rowat
Anadulce Hernandez-Herrera
Anil K Sood
Chad V Pecot
Clara K Chan
Cristian Coarfa
Denise Brooks
Emilia Lim
Gordon Robertson
P2860
P304
25930-25948
P356
10.18632/ONCOTARGET.8412
P407
P577
2016-05-01T00:00:00Z